LCN2 and pachyonychia congenita: Similarly, TIMP-1 has been reported as a potential biomarker for the early detection of PC [60], particularly in familial PC in association with LCN2 [63], while Galectin-3 was described as a putative biomarker for screening and diagnosis, as well as an independent prognostic indicator in PC [64].